Literature DB >> 17312172

TCR signaling antagonizes rapid IP-10-mediated transendothelial migration of effector memory CD4+ T cells.

Thomas D Manes1, Stephen L Shiao, Thomas J Dengler, Jordan S Pober.   

Abstract

Human microvascular endothelial cells (ECs) constitutively express MHC class II in peripheral tissues, the function of which remains unknown. In vitro assays have established that the recognition of EC MHC class II can affect cytokine expression, proliferation, and delayed transendothelial migration of allogeneic memory, but not naive, CD4+ T cells. Previously, we have shown that effector memory CD4+ T cells will rapidly transmigrate in response to the inflammatory chemokine IFN-gamma-inducible protein-10 (IP-10) in a process contingent upon the application of venular levels of shear stress. Using two models that provide polyclonal TCR signaling by ECs in this flow system, we show that TCR engagement antagonizes the rapid chemokine-dependent transmigration of memory CD4+ T cells. Inhibitor studies suggest that TCR signaling downstream of Src family tyrosine kinase(s) but upstream of calcineurin activation causes memory CD4+ T cell arrest on the EC surface, preventing the transendothelial migration response to IP-10.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312172     DOI: 10.4049/jimmunol.178.5.3237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Authors:  Birgit Fogal; Tai Yi; Chen Wang; Deepak A Rao; Amir Lebastchi; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

2.  Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

3.  Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

Review 4.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

5.  Blocking MHC class II on human endothelium mitigates acute rejection.

Authors:  Parwiz Abrahimi; Lingfeng Qin; William G Chang; Alfred L M Bothwell; George Tellides; W Mark Saltzman; Jordan S Pober
Journal:  JCI Insight       Date:  2016-01-21

6.  Antigen recognition is facilitated by invadosome-like protrusions formed by memory/effector T cells.

Authors:  Peter T Sage; Laya M Varghese; Roberta Martinelli; Tracey E Sciuto; Masataka Kamei; Ann M Dvorak; Timothy A Springer; Arlene H Sharpe; Christopher V Carman
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

7.  TCR-driven transendothelial migration of human effector memory CD4 T cells involves Vav, Rac, and myosin IIA.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

8.  CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells.

Authors:  Jonathan C Choy; Tai Yi; Deepak A Rao; George Tellides; Karen Fox-Talbot; William M Baldwin; Jordan S Pober
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

9.  Significant Differences in Antigen-Induced Transendothelial Migration of Human CD8 and CD4 T Effector Memory Cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

10.  T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.

Authors:  Peter Newton; Graeme O'Boyle; Yvonne Jenkins; Simi Ali; John A Kirby
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.